Kendall Capital Partners

Kendall Capital Partners is a next-generation venture capital firm headquartered in Boston—at the epicenter of global biotech. We invest in early-to-commercial stage life sciences and healthcare companies solving the most pressing medical challenges of our time. In a world fragmented by geopolitics and resource constraints, healthcare remains one of the few domains of global cooperation. Aging populations, rising disease burdens, and accelerating scientific discovery create unparalleled opportunities—especially for innovation rooted in elite academic research. We partner with world-class founders, scientific labs, and institutions to turn deep science into scalable businesses. Our mandate is bold but clear: Back breakthroughs. Build enduring companies. Deliver health impact at scale. At Kendall Capital Partners, we don’t just back products — we back platforms, pioneers, and paradigm shifts. Our focus is on the frontier: the most disruptive and durable scientific breakthroughs with the potential to reshape global healthcare and deliver outsized returns.